Long-term effects of perindopril on left ventricular structure and function in patients with stable coronary artery disease: A conventional and Doppler tissue echocardiographic pilot study

Journal of Cardiovascular Medicine

Volumn 10, Issue 10, 2009, Pages 781-786

  Pelà, Giovanna ^a   Pattoneri, Paolo ^a   Passera, Mariadele ^a   Tirabassi, Giovanni ^a   Reverberi, Claudio ^a   Montanari, Alberto ^a   Gherli, Tiziano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Angiotensin converting enzyme inhibition; Doppler tissue echocardiography; echocardiography; left ventricular function; perindopril; stable coronary disease

Indexed keywords

PERINDOPRIL; PLACEBO;

A WAVE; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART VENTRICLE FUNCTION; HUMAN; MALE; MITRAL VALVE; MULTICENTER STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PERINDOPRIL; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 70349086135     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832dbfe9     Document Type: Article

References (27)

1. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality and on congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314:1547-1552.
2. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310.
3. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
4. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.
5. Kjekshus J, Swedberg K, Snapinn S. Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS trial Group. Am J Cardiol 1992; 69:103-107.
6. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327:669-677.
7. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, et al., for the SOLVD Investigators. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Circulation 1995; 91:2573-2581.
8. Ferrari R, and the PREAMI Investigators. Effects of angiotensin- converting enzyme inhibition with perindopril on left ventricular remodelling and clinical outcome. Results of the randomised perindopril and remodelling in elderly with acute myocardial infarction (PREAMI) study. Arch Intern Med 2006; 166:659-666.
9. Fox KM; the European trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA trial). Lancet 2003; 362:782-788.
10. Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function. Int J Cardiol 2007; 121:57-61.
11. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30:474-480.
12. Oki T, Tabata T, Yamada H, Wakatsuki T, Shinohara H, Nishikado A, et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997; 79:921-928. (Pubitemid 27197927)
13. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30:1527-1533.
14. Gulati VK, Katz WE, Follansbee WP, Gorcsan J. Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol 1996; 77:979-984.
15. Galiuto L, Ignone G, DeMaria AN. Contraction and relaxation velocities of the normal left ventricle using pulsed-wave tissue Doppler echocardiography. Am J Cardiol 1998; 81:609-614.
16. Hedman A, Samad BA, Larsson T, Zuber E, Nordlander R, Alam M. Improvement in diastolic left ventricular function after coronary artery bypass grafting as assessed by recordings of mitral annular velocity using Doppler tissue imaging. Eur J Echo 2005; 6:202-209.
17. Muller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Am J Hypertens 2006; 19:927-936.
18. Solomon SD, Janardhanan R, Verna A, Bourgoun M, Daley WL, Purkayastha D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomized trial. Lancet 2007; 369:2079-2087.
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55:613-618.
20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
21. Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001; 37:278-285.
22. Pelà G, Bruschi G, Cavatorta A, Manca C, Cabassi A, Borghetti A. Doppler tissue echocardiography: myocardial wall motion velocities in essential hypertension. Eur J Echo 2001; 2:108-117.
23. Pelà G, Tirabassi G, Pattoneri P, Pavone L, Garini G, Bruschi G. Cardiac involvement in the Churg-Strauss syndrome. Am J Cardiol 2006; 97:1519-1524.
24. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging. A new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007; 49:1903-1914.
25. Wang M, Yip GWK, Wang AYM, Zhang Y, Ho PY, Tse MK, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003; 41:820-826.
26. Bots ML, Remme WJ, Luscher TF, Grobbee DE, on behalf of the EUROPAPERFECT investigators. Perindopril-Function of the Endothelium in Coronary Artery Disease trial: the PERFECT study, a sub-study of EUROPA. Cardiovasc Drugs Ther 2002; 16:227-236.
27. Ceconi C, Fox KM, Remme WJ, Simoons ML, Bertrand M, Parrinello G, et al. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007; 73:237-246.